NEW YORK (GenomeWeb) – Becton Dickinson today reported a 46 percent increase year over year in fiscal 2016 first quarter revenues, with growth in its medical segment topping 92 percent.

For the three months ended Dec. 31, BD reported revenues of $2.99 billion compared to $2.05 billion in the same quarter last year, but below analysts' consensus estimate of $3.03 billion. On a currency-neutral basis, revenues increased about 54 percent year over year, BD said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Sponsored by

This webinar will provide a first-hand look at how a leading pathology lab implemented a next-generation sequencing panel to capture comprehensive molecular tumor profiles.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.